NEDD4L acts as an oncogene and is expressed at low levels in tumors such as breast cancer [31], colon adenocarcinoma [41], glioma [42], esophageal cancer [43], lung cancer [28], hepatocellular cancer [25], and endometrial cancer [30], as it does in ccRCC. Here, NEDD4L is linked to breast cancer.